Where can I buy mitotane through formal channels in China?

Mitotane, also known as Mitotane, is a drug used to treat adrenocortical cancer (ACC). At present, the drug has completed the marketing approval of the original drug in China, and patients can purchase it through the pharmacies of some tertiary hospitals or oncology hospitals. However, because mitotane has been on the market for a short time in China and its coverage is not wide, not all hospitals can supply it immediately. Patients need to contact the hospital pharmacy or tumor center in their area in advance to confirm whether it is in stock. In addition, some formal third-party pharmaceutical service platforms may also provide the drug, but be sure to ensure that the source is legal and compliant.

As of now, mitotane has not been included in the national medical insurance directory, so patients need to bear all costs when purchasing it. Considering its special indications and high price burden, it is recommended that patients consult their attending doctor about the medication cycle and alternative options when seeing a doctor. They can also learn whether there are relevant charitable aid, clinical trials or patient assistance programs through the hospital's clinical pathways or specialized disease management projects. Some hospitals may partner with pharmaceutical companies to provide limited quantities of assistance medications to specific patients.

In foreign markets, the original version of mitotane mainly includes the European version and the Turkish version, both of which are 500mg*100 tablets. The price is relatively high, usually around 9000 RMB. The specific price will vary due to exchange rate fluctuations and different procurement channels. Some qualified patients may obtain the drug through cross-border medical services or overseas drug purchasing platforms, but they need to be wary of the risk of unguaranteed drug quality through informal channels and give priority to channels recommended by qualified overseas pharmacies or hospitals.

For patients with heavy financial burden, overseas generic drugs are a relatively economical choice. For example, the generic version of mitotane produced in Laos has the same specification of 500mg*100 tablets, and the price is around 2000 multiple yuan. Although the price is more affordable, it is recommended that patients fully communicate with their doctors before use to confirm whether the efficacy and safety of generic drugs meet their treatment needs, and ensure that they are purchased through compliant channels. In short, whether you choose domestic original research, overseas original research or generic drugs, ensuring drug quality and efficacy is the primary consideration.

Reference materials:https://go.drugbank.com/drugs/DB00648